Neurodevelopment of children exposed in utero to antidepressant drugs

New England Journal of Medicine

Volumn 336, Issue 4, 1997, Pages 258-262

  Nulman, Irena ^a   Rovet, Joanne ^a,b   Stewart, Donna E ^c   Wolpin, Jacob ^a   Gardner, H Allan ^d   Theis, Jochen G W ^a   Kulin, Nathalie ^a   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d Oshawa General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; IMIPRAMINE; MAPROTILINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ADULT; ARTICLE; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE DEVELOPMENT; LANGUAGE TEST; MAJOR CLINICAL STUDY; MENTAL DEVELOPMENT; MENTAL TEST; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APTITUDE TESTS; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; INFANT; INFANT, NEWBORN; INTELLIGENCE; LANGUAGE DEVELOPMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 0031022182     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701233360404     Document Type: Article

References (33)

1. Weissman MM, Bruce ML, Leaf PJ, Florio LP, Holzer C III. Affective disorders. In: Robins LN, Regier DA, eds. Psychiatric disorders in America: the Epidemiologic Catchment Area study. New York: Free Press, 1991:53-80.
2. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I. Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
3. Koren G, ed. Maternal-fetal toxicology: a clinician's guide. 2nd ed. New York: Marcel Dekker, 1994.
4. Cohen LS, Heller VL, Rosenbaum JF. Treatment guidelines for psychotropic drug use in pregnancy. Psychosomatics 1989;30:25-33.
5. Potter WZ, Rudorfer MV, Manji H. The pharmacologic treatment of depression. N Engl J Med 1991;325:633-42.
6. Gram LF. Fluoxetine. N Engl J Med 1994;331:1354-61. [Erratum, N Engl J Med 1995;332:343.]
7. Pande AC, Sayler ME. Adverse events and treatment discontinuations in fluoxetine clinical trials. Int Clin Psychopharmacol 1993;8:267-9.
8. Borys DJ, Setzer SC, Ling LJ, Reisdorf JJ, Day LC, Krenzelok EP. Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med 1992;10:115-20.
9. Shepard TH. Catalog of teratogenic agents. 5th ed. Baltimore: Johns Hopkins University Press, 1986.
10. Nulman I, Koren G. The safety of fluoxetine during pregnancy and lactation. Teratology 1996;53:304-8.
11. Vorhees CV, Acuff-Smith KD, Schilling MA, Fisher JE, Moran MS, Buelke-Sam J. A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam Appl Toxicol 1994;23:194-205.
12. Sim M. Imipramine and pregnancy. BMJ 1972;2:45.
13. Crombie DL, Pinsent RJ, Fleming D. Imipramine in pregnancy. BMJ 1972;1:745.
14. Possible teratogenicity of tricyclic antidepressants. Lancet 1972;1:838-9.
15. Idanpaan-Heikkila J, Saxen L. Possible teratogenicity of imipramine-chloropyramine. Lancet 1973;2:282-4.
16. Kuenssberg EV, Knox JD. Imipramine in pregnancy. BMJ 1972;2:292.
17. Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991;21:157-71.
18. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269: 2246-8.
19. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335: 1010-5.
20. Koren G, Bologa M, Long D, Feldman Y, Shear NH. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 1989;160:1190-4.
21. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, Tex.: Psychological Corporation, 1993.
22. McCarthy D. McCarthy Scales of Children's Abilities. New York: Psychological Corporation, 1972.
23. Fullard W, McDevitt S, Carey W. Toddler Temperament Scale: for 1 to 3 year old children. Philadelphia: Temple University Press, 1978.
24. McDevitt SC, Carey WB. The measurement of temperament in 3-7 year old children. J Child Psychol Psychiatry 1978;19:245-53.
25. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 profile. Burlington: University of Vermont Department of Psychiatry, 1991.
26. Reynell JK. Reynell Developmental Language Scales manual. 2nd rev. (Huntley M.) Windsor, England: NFER-NELSON Publishing, 1985.
27. Wechsler D. Wechsler Adult Intelligence Scale. Rev. ed. New York: Psychological Corporation, 1981.
28. Hollingshead AB. Four factor index of social status. New Haven, Conn.: Yale University Department of Sociology, 1975.
29. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-71.
30. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
31. Hudson WW. The clinical measurement package: a field manual. Homewood, Ill.: Dorsey Press, 1982.
32. Goodman SH. Understanding the effects of depressed mothers on their children. Prog Exp Pers Psychopathol Res 1992;15:47-109.
33. Morrison HL, ed. Children of depressed parents: risk, identification, and intervention. New York: Grune & Stratton, 1983.